Liver Disease News and Research

RSS
SLU researchers study investigational vaccine for yellow fever

SLU researchers study investigational vaccine for yellow fever

New diagnostic model may become cheaper and easier alternative to screen for NAFLD

New diagnostic model may become cheaper and easier alternative to screen for NAFLD

Changes in cavefish metabolism could lead to new insights into diabetes

Changes in cavefish metabolism could lead to new insights into diabetes

Impact of diet may depend on individual’s genetic composition

Impact of diet may depend on individual’s genetic composition

CNIO study shows proinflammatory molecule IL-17A can be key factor in development of NASH and HCC

CNIO study shows proinflammatory molecule IL-17A can be key factor in development of NASH and HCC

New home-based intervention aims to improve health outcomes of children of South Asian immigrants

New home-based intervention aims to improve health outcomes of children of South Asian immigrants

Vigorous and moderate exercise have same effect on patients with NAFLD

Vigorous and moderate exercise have same effect on patients with NAFLD

Study finds delayed onset of illness for centenarians than younger counterparts

Study finds delayed onset of illness for centenarians than younger counterparts

FIB-4 index predicts HBV-related HCC

FIB-4 index predicts HBV-related HCC

SLU researchers receive federal grant to study Zika virus

SLU researchers receive federal grant to study Zika virus

Targeted molecular therapy reduces initial development of NAFLD in mice

Targeted molecular therapy reduces initial development of NAFLD in mice

Researchers develop in vitro model system for investigating etiology of NAFLD

Researchers develop in vitro model system for investigating etiology of NAFLD

Epclusa drug receives FDA approval for treating adult patients with chronic HCV

Epclusa drug receives FDA approval for treating adult patients with chronic HCV

Pioglitazone effective in diabetes patients with NASH

Pioglitazone effective in diabetes patients with NASH

MLDA of 21 appears to protect against alcohol-related mortality later in life

MLDA of 21 appears to protect against alcohol-related mortality later in life

SLU to conduct human clinical trial of vaccine to protect people from Zika virus

SLU to conduct human clinical trial of vaccine to protect people from Zika virus

Salvage inotuzumab ozogamicin improves ALL outcomes

Salvage inotuzumab ozogamicin improves ALL outcomes

Clinical trial finds pioglitazone drug safe and effective for NASH patients

Clinical trial finds pioglitazone drug safe and effective for NASH patients

New studies provide future treatment strategies for stomach ulcers, IBD and alcoholic liver disease

New studies provide future treatment strategies for stomach ulcers, IBD and alcoholic liver disease

Disruption of SVIP protein can lead to cardiovascular, fatty liver disease

Disruption of SVIP protein can lead to cardiovascular, fatty liver disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.